The Jacobs School of Medicine and Biomedical Sciences and the School of Engineering and Applied Sciences are hosting and sponsoring this year’s Vasculata, the national summer conference for ...
When it comes to cardiovascular health, few supplements have sparked as much public interest — or confusion — as nattokinase.
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing "off the shelf" allogeneic cell therapies for serious medical conditions, today ...
People living with both obesity and type 2 diabetes face a sharply elevated risk of heart failure, atherosclerotic ...
Recently published Fuchs Endothelial Corneal Dystrophy Market Insights report includes a comprehensive understanding of ...
Open access publishing makes scientific research more accessible to researchers, students, and the general public. Discover ...